WallStreetZenWallStreetZen

NASDAQ: TKNO
Alpha Teknova Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their TKNO stock forecasts and price targets.

Forecast return on equity

Is TKNO forecast to generate an efficient return?

Forecast return on assets

Is TKNO forecast to generate an efficient return on assets?

TKNO revenue forecast

What is TKNO's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$36.7M+0.04%
Avg 2 year Forecast
$51.7M+40.93%
Avg 3 year Forecast
$96.5M+163.06%
TKNO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TKNO revenue growth forecast

How is TKNO forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
26.98%
Industry
10.12%
Market
9.2%
TKNO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TKNO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TKNO vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TKNO$2.00N/AN/A
ETON$3.19$10.00+213.48%Buy
ASRT$0.77$3.50+352.78%Strong Buy
RGC$5.55N/AN/A
DERM$3.48$8.50+144.25%Strong Buy

Alpha Teknova Stock Forecast FAQ

What is TKNO's revenue growth forecast for 2024-2026?

(NASDAQ: TKNO) Alpha Teknova's forecast annual revenue growth rate of 26.98% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.12%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Alpha Teknova's revenue in 2024 is $36,684,000.On average, 1 Wall Street analysts forecast TKNO's revenue for 2024 to be $1,498,218,303, with the lowest TKNO revenue forecast at $1,498,218,303, and the highest TKNO revenue forecast at $1,498,218,303. On average, 2 Wall Street analysts forecast TKNO's revenue for 2025 to be $2,110,569,108, with the lowest TKNO revenue forecast at $1,918,699,189, and the highest TKNO revenue forecast at $2,302,439,027.

In 2026, TKNO is forecast to generate $3,939,456,846 in revenue, with the lowest revenue forecast at $3,939,456,846 and the highest revenue forecast at $3,939,456,846.

If you're new to stock investing, here's how to buy Alpha Teknova stock.

What is TKNO's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: TKNO) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.04%.

What is TKNO's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: TKNO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.